SH3P2 Antibody

What is SH3P2 and what cellular processes is it involved in?

SH3P2 (SH3 DOMAIN-CONTAINING PROTEIN2) is a BAR domain-containing protein that functions as a membrane-associated protein with the ability to bind phosphatidylinositol 3-phosphate . Studies have demonstrated that SH3P2 plays an essential role in autophagy, particularly in autophagosome formation and biogenesis . It associates with the phosphatidylinositol 3-kinase (PI3K) complex to facilitate autophagosome formation, with evidence showing that SH3P2 promotes PI3K foci formation . Furthermore, when plants are treated with wortmannin (a PI3K inhibitor), SH3P2 is inhibited from translocating to autophagosomes . Beyond autophagy, SH3P2 has been implicated in clathrin-mediated endocytosis (CME) through its interactions with dynamin-related proteins (DRPs) .

How do SH3P2 antibodies perform in detection applications?

SH3P2 antibodies have demonstrated high specificity and reliability in various experimental applications. In immunoblot analysis using proteins isolated from both wild-type Arabidopsis and transgenic SH3P2-GFP plants, SH3P2 antibodies specifically recognized both endogenous SH3P2 and the GFP fusion proteins . For immunofluorescence applications, signals from SH3P2 antibody labeling largely colocalized with SH3P2-GFP before and after treatments that induce autophagy, such as benzothiadiazole (BTH), demonstrating the high specificity of these antibodies . When studying autophagy dynamics, researchers found that in cells subjected to autophagy induction, most SH3P2-GFP punctae colocalized with immunofluorescent signals from ATG8e antibodies, confirming that SH3P2 punctae are indeed autophagosomes or related structures .

What controls should be included when using SH3P2 antibodies?

When working with SH3P2 antibodies, several controls are essential to ensure reliable results:

• Include wild-type samples alongside transgenic or experimental samples to validate antibody specificity

• Use both positive controls (tissues known to express SH3P2) and negative controls (tissues with low expression or knockout mutants where available)

• For colocalization studies, include ATG8e antibodies as markers for autophagosomes when studying autophagy

• When examining dynamic processes, incorporate time-course analyses with appropriate treatments (e.g., nitrogen starvation or BTH for autophagy induction)

• Include PI3K inhibitors like wortmannin as functional controls when studying SH3P2 translocation to autophagosomes

These controls are particularly important given that SH3P2 punctae do not fully overlap with anti-ATG8e signals, suggesting that distinct SH3P2 foci might represent autophagosome precursors rather than mature autophagosomes .

How can SH3P2 antibodies be used to study its interaction with the PI3K complex?

SH3P2 antibodies provide valuable tools for investigating SH3P2's interactions with the PI3K complex through several methodological approaches:

• Co-immunoprecipitation (Co-IP): SH3P2 antibodies can be used to pull down SH3P2 complexes from plant lysates, followed by immunoblotting for PI3K components to confirm interaction .

• Immunofluorescence colocalization: Dual labeling with SH3P2 antibodies and markers for PI3K components can visualize their spatial relationship during autophagy induction .

• Proximity ligation assays: This technique can detect protein-protein interactions in situ when the proteins are in close proximity, offering higher sensitivity than conventional colocalization studies.

• Sequential immunoprecipitation: For complex interaction networks, sequential IP with SH3P2 antibodies followed by PI3K component antibodies can help identify specific subcomplexes.

Research has shown that SH3P2 associates with the PI3K complex and promotes PI3K foci formation, critical steps in autophagosome formation . When designing experiments to study this interaction, it's important to consider appropriate autophagy induction methods, as SH3P2 response to BTH treatment is more pronounced than that of nitrogen starvation treatment .

What methodological approaches can resolve SH3P2's role in membrane dynamics?

SH3P2's BAR domain suggests a role in membrane curvature and dynamics, which can be studied using these approaches:

• In vitro membrane binding assays: Using purified SH3P2 protein and artificial liposomes containing phosphatidylinositol 3-phosphate to assess direct membrane binding .

• Membrane deformation assays: Electron microscopy can visualize how SH3P2 affects membrane morphology, as in vitro data show that SH3P2 can deform membranes .

• Live cell imaging with SH3P2 antibodies: To track SH3P2 dynamics during membrane-related processes, particularly using techniques like Total Internal Reflection Fluorescence Microscopy (TIRF-M) which is excellent for visualizing events at the plasma membrane .

• Super-resolution microscopy: Techniques like STORM or PALM using SH3P2 antibodies can resolve the precise localization of SH3P2 during membrane remodeling events.

Research has demonstrated that SH3P2 is a membrane-associated protein that binds specifically to phosphatidylinositol 3-phosphate, and this association is crucial for its role in autophagosome formation . Experiments should incorporate appropriate controls, including PI3K inhibitors like wortmannin, which inhibits SH3P2 translocation to autophagosomes .

How can SH3P2 antibodies be employed to investigate its role in the DRP2 interaction network?

SH3P2 antibodies can be instrumental in elucidating the interactions between SH3P2 and Dynamin-Related Proteins (DRPs), particularly DRP2A and DRP2B, through these methodologies:

• Co-immunoprecipitation with SH3P2 antibodies: This approach can identify native complexes containing both SH3P2 and DRP2 proteins in plant extracts .

• Domain-specific interaction analysis: Combined with truncation mutants or domain deletions, immunoprecipitation with SH3P2 antibodies can map specific interaction domains, as demonstrated by studies showing that the SH3 domain of SH3P2 interacts with the PRM2 motif of DRP2B .

• In situ interaction visualization: Using fluorescently tagged proteins alongside immunolabeling with SH3P2 antibodies can reveal the spatiotemporal dynamics of these interactions during endocytosis .

• Advanced imaging: TIRF-M imaging of SH3P2 and DRP2 can detect foci that are spatiotemporally correlated at the plasma membrane, providing evidence for functional interaction during clathrin-mediated endocytosis .

Studies have shown that the SH3 domain of SH3P2 interacts specifically with the PRM2 motif in the C-terminal region of DRP2B, while PRM1 cannot interact with the SH3 domain alone . Point mutations in PRM2 (changing RL to AA and PQ to QS) prevent interaction with SH3P2, while mutations in PRM1 do not affect this interaction . This interaction specificity provides valuable information for designing experiments targeting the SH3P2-DRP2 network.

What considerations are important when interpreting colocalization of SH3P2 with DRP2 proteins?

When analyzing SH3P2 colocalization with DRP2 proteins, researchers should consider several factors to accurately interpret their findings:

• Temporal dynamics: Research indicates that recruitment of DRP2A starts before SH3P2 recruitment, suggesting distinct temporal phases that must be accounted for in experimental design .

• Partial colocalization: A significant amount of DRP2A does not colocalize with SH3P2, indicating that DRP2s can be recruited through alternative mechanisms independent of SH3P2 .

• Functional redundancy: Consider the possibility of functional redundancy among SH3P family members (SH3P1, SH3P2, SH3P3) when interpreting colocalization data .

• Resolution limitations: Standard confocal microscopy may not provide sufficient resolution to distinguish between truly interacting proteins and those that are merely in proximity, necessitating super-resolution approaches or proximity ligation assays.

Studies using TIRF-M to analyze the dynamics of DRP2A-PRM2-GFP (containing mutations that prevent interaction with SH3P2) showed that despite the interaction mutation, DRP2s were still efficiently recruited to clathrin-coated vesicle formation sites . This suggests that while in vitro data support direct interaction between SH3P2 and DRP2s, the functional significance of this interaction in vivo may be more complex than anticipated .

How do mutations in interaction domains affect SH3P2 function in endocytosis?

Analysis of interaction domain mutations provides valuable insights into SH3P2's functional mechanisms:

• Effect of PRM mutations in DRP2: While point mutations in the PRM2 motif of DRP2B abolish interaction with SH3P2 in vitro, plants expressing DRP2A or DRP2B with PRM2 mutations show minimal changes in endocytic dynamics . Specifically:

  • DRP2A-PRM2-GFP shows a slightly reduced mean lifetime (43.72±0.1s) compared to wild-type DRP2A (46.12±0.6s)

  • DRP2B-PRM2 mutant shows no significant change in either lifetime or foci density compared to wild-type DRP2B

  • Approximately 60% of CLC2 foci still colocalize with DRP2A-PRM2 despite the mutation

• SH3 domain overexpression: Overexpression of the SH3 domain of SH3P2 (without membrane binding domain) does not significantly affect clathrin light chain 2 (CLC2) dynamics, contrary to expectations that it would sequester DRP2s and impair endocytosis .

• Triple sh3p mutants: In sh3p1,2,3 triple mutants:

  • DRP2A dynamics remain unchanged compared to controls

  • CLC2 lifetime shows a slight increase of 1.7s in the mutant background

  • Density of TPLATE × CLC2 positive events is slightly increased in the mutant

These findings suggest that while SH3P2 interacts with DRP2 proteins in vitro, this interaction may be functionally redundant with other recruitment mechanisms in vivo, highlighting the complexity of endocytic protein networks .

What are the optimal detection methods for studying SH3P2 dynamics during autophagy?

For studying SH3P2 dynamics during autophagy, researchers should consider these optimal detection methods:

• Fluorescently tagged SH3P2: SH3P2-GFP transgenic lines have been validated to respond to autophagy induction similarly to endogenous SH3P2 . This approach allows real-time visualization of SH3P2 dynamics.

• Immunofluorescence with anti-SH3P2 antibodies: This method has been validated for specificity and can be combined with autophagosome markers like ATG8e . For optimal results:

  • Use appropriate fixation protocols for plant tissues

  • Include autophagy inducers like nitrogen starvation or BTH in experimental design

  • Consider combined treatments (e.g., nitrogen starvation with Concanamycin A) for enhanced visualization of autophagic structures

• Colocalization with established markers: Using dual labeling with SH3P2 antibodies and ATG8e antibodies provides valuable information about autophagosome formation stages . Importantly, research has shown that SH3P2 punctae do not fully overlap with ATG8e signals, suggesting that SH3P2 may mark autophagosome precursors .

• Time-course analysis: This approach is critical as different autophagy induction methods show varying temporal dynamics - BTH treatment produces more pronounced autophagy induction than nitrogen starvation .

For all these methods, it's essential to include appropriate controls, such as PI3K inhibitor treatments, which have been shown to inhibit SH3P2 translocation to autophagosomes .

What are common pitfalls when using SH3P2 antibodies and how can they be addressed?

When working with SH3P2 antibodies, researchers may encounter several challenges that can be addressed with these strategies:

• Background or non-specific signals:

  • Solution: Include stringent blocking steps using BSA or normal serum

  • Validate antibody specificity using SH3P2 knockout or knockdown lines

  • Compare signals with fluorescently tagged SH3P2 as demonstrated in previous research

• Weak signal detection:

  • Solution: Optimize fixation conditions for plant tissues

  • Consider signal amplification methods such as tyramide signal amplification

  • Induce autophagy with combined treatments (e.g., nitrogen starvation with Concanamycin A) which significantly increases SH3P2-positive compartments

• Difficulties distinguishing specific structures:

  • Solution: Use colocalization with established markers like ATG8e for autophagosomes

  • Apply super-resolution microscopy techniques for improved spatial resolution

  • Remember that not all SH3P2 punctae colocalize with ATG8e, as some may represent autophagosome precursors

• Variability in autophagy induction:

  • Solution: Include time-course analyses, as different induction methods (BTH vs. nitrogen starvation) show different temporal dynamics

  • Use standardized conditions and multiple biological replicates

  • Include appropriate positive controls for autophagy induction

These approaches can help ensure reliable and reproducible results when using SH3P2 antibodies for research applications.

How can researchers resolve contradictory findings between in vitro and in vivo studies of SH3P2?

The search results highlight several discrepancies between in vitro and in vivo findings regarding SH3P2 function, particularly in its interactions with DRP2 proteins. Here are strategies to address and understand these contradictions:

• Complementary methodological approaches:

  • Combine biochemical assays (pull-down, Y2H) with live-cell imaging

  • Use both fixed tissue immunolabeling and dynamic imaging approaches

  • Employ genetic approaches (mutations, knockouts) alongside protein interaction studies

• Consideration of functional redundancy:

  • Design experiments that account for potential redundancy among SH3P family members

  • Study triple mutants (sh3p1,2,3) alongside single mutants

  • Consider redundancy in interaction partners, as DRP2s may be recruited through multiple mechanisms

• Domain-specific analyses:

  • Use domain truncations or specific point mutations to precisely map functional interactions

  • The differing results with PRM mutations highlight the importance of domain-specific approaches

  • Consider that interactions demonstrated in vitro may have different functional significance in vivo

• Temporal dynamics considerations:

  • Account for the timing of protein recruitment, as DRP2A recruitment starts before SH3P2 recruitment

  • Design time-resolved experiments that can capture transient interactions

  • Use photoactivatable or photoswitchable tags to track specific subpopulations of proteins over time

These approaches can help researchers bridge the gap between in vitro findings (such as the clear interaction between SH3P2's SH3 domain and DRP2's PRM2) and in vivo observations (such as the minimal effect of PRM2 mutations on endocytic dynamics) .